162 related articles for article (PubMed ID: 23125446)
1. Use of human monoclonal antibodies to treat Chikungunya virus infection.
Fric J; Bertin-Maghit S; Wang CI; Nardin A; Warter L
J Infect Dis; 2013 Jan; 207(2):319-22. PubMed ID: 23125446
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
[TBL] [Abstract][Full Text] [Related]
3. Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus.
Pal P; Dowd KA; Brien JD; Edeling MA; Gorlatov S; Johnson S; Lee I; Akahata W; Nabel GJ; Richter MK; Smit JM; Fremont DH; Pierson TC; Heise MT; Diamond MS
PLoS Pathog; 2013; 9(4):e1003312. PubMed ID: 23637602
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model.
Goh LY; Hobson-Peters J; Prow NA; Gardner J; Bielefeldt-Ohmann H; Pyke AT; Suhrbier A; Hall RA
Clin Immunol; 2013 Dec; 149(3):487-97. PubMed ID: 24239837
[TBL] [Abstract][Full Text] [Related]
5. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
[TBL] [Abstract][Full Text] [Related]
6. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.
Selvarajah S; Sexton NR; Kahle KM; Fong RH; Mattia KA; Gardner J; Lu K; Liss NM; Salvador B; Tucker DF; Barnes T; Mabila M; Zhou X; Rossini G; Rucker JB; Sanders DA; Suhrbier A; Sambri V; Michault A; Muench MO; Doranz BJ; Simmons G
PLoS Negl Trop Dis; 2013; 7(9):e2423. PubMed ID: 24069479
[TBL] [Abstract][Full Text] [Related]
7. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.
Metz SW; Martina BE; van den Doel P; Geertsema C; Osterhaus AD; Vlak JM; Pijlman GP
Vaccine; 2013 Dec; 31(51):6092-6. PubMed ID: 24099875
[TBL] [Abstract][Full Text] [Related]
8. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.
Clayton AM
J Infect Dis; 2016 Dec; 214(suppl 5):S506-S509. PubMed ID: 27920182
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.
Lee CY; Kam YW; Fric J; Malleret B; Koh EG; Prakash C; Huang W; Lee WW; Lin C; Lin RT; Renia L; Wang CI; Ng LF; Warter L
PLoS Pathog; 2011 Dec; 7(12):e1002390. PubMed ID: 22144891
[TBL] [Abstract][Full Text] [Related]
11. Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.
Smith SA; Silva LA; Fox JM; Flyak AI; Kose N; Sapparapu G; Khomandiak S; Ashbrook AW; Kahle KM; Fong RH; Swayne S; Doranz BJ; McGee CE; Heise MT; Pal P; Brien JD; Austin SK; Diamond MS; Dermody TS; Crowe JE
Cell Host Microbe; 2015 Jul; 18(1):86-95. PubMed ID: 26159721
[TBL] [Abstract][Full Text] [Related]
12. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
Fox JM; Long F; Edeling MA; Lin H; van Duijl-Richter MKS; Fong RH; Kahle KM; Smit JM; Jin J; Simmons G; Doranz BJ; Crowe JE; Fremont DH; Rossmann MG; Diamond MS
Cell; 2015 Nov; 163(5):1095-1107. PubMed ID: 26553503
[TBL] [Abstract][Full Text] [Related]
13. A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.
Brandler S; Ruffié C; Combredet C; Brault JB; Najburg V; Prevost MC; Habel A; Tauber E; Desprès P; Tangy F
Vaccine; 2013 Aug; 31(36):3718-25. PubMed ID: 23742993
[TBL] [Abstract][Full Text] [Related]
14. Serological correlates of immune protection conferred by Chikungunya virus infection.
Sheela PJ; Sumathy K
Acta Virol; 2013; 57(4):471-3. PubMed ID: 24294963
[TBL] [Abstract][Full Text] [Related]
15. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.
Kose N; Fox JM; Sapparapu G; Bombardi R; Tennekoon RN; de Silva AD; Elbashir SM; Theisen MA; Humphris-Narayanan E; Ciaramella G; Himansu S; Diamond MS; Crowe JE
Sci Immunol; 2019 May; 4(35):. PubMed ID: 31101672
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test.
Litzba N; Schuffenecker I; Zeller H; Drosten C; Emmerich P; Charrel R; Kreher P; Niedrig M
J Virol Methods; 2008 Apr; 149(1):175-9. PubMed ID: 18294706
[TBL] [Abstract][Full Text] [Related]
17. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response.
Her Z; Malleret B; Chan M; Ong EK; Wong SC; Kwek DJ; Tolou H; Lin RT; Tambyah PA; Rénia L; Ng LF
J Immunol; 2010 May; 184(10):5903-13. PubMed ID: 20404274
[TBL] [Abstract][Full Text] [Related]
18. Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.
Malonis RJ; Earnest JT; Kim AS; Angeliadis M; Holtsberg FW; Aman MJ; Jangra RK; Chandran K; Daily JP; Diamond MS; Kielian M; Lai JR
Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507983
[TBL] [Abstract][Full Text] [Related]
19. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection.
Ramful D; Sampériz S; Fritel X; Michault A; Jaffar-Bandjee MC; Rollot O; Boumahni B; Gérardin P
J Infect Dis; 2014 Jun; 209(11):1726-30. PubMed ID: 24338351
[TBL] [Abstract][Full Text] [Related]
20. Expression of the capsid protein of Chikungunya virus in a baculovirus for serodiagnosis of Chikungunya disease.
Cho B; Kim J; Cho JE; Jeon BY; Park S
J Virol Methods; 2008 Dec; 154(1-2):154-9. PubMed ID: 18761376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
